{
    "2019-10-07": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Is Novartis AG (NVS) A Good Stock To Buy According To Hedge Funds?",
                "features": {
                    "keywords": [
                        "Novartis",
                        "NVS",
                        "Hedge Funds",
                        "Good Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AstraZeneca's Fasenra Gets FDA Nod for Self-Administration",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Fasenra",
                        "FDA",
                        "Self-Administration"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}